Omega Healthcare Named a Leader in the Everest Group Revenue Cycle Management (RCM) Operations PEAK Matrix Assessment, 2024
Omega Healthcare Price Target Maintained With a $45.00/Share by BMO Capital
Omega Healthcare Raised to Outperform From Market Perform by BMO Capital
BMO Capital Upgrades Omega Healthcare Investors Inc(OHI.US) to Buy Rating, Maintains Target Price $45
Omega Healthcare Investors Shares Slipped for Seven Consecutive Sessions
5 Analysts Assess Omega Healthcare Invts: What You Need To Know
Express News | Omega Healthcare Investors Inc : Citigroup Raises Target Price to $45 From $42
Buy-rated Stocks With Passive and Active Net Buying Tailwinds – Citi
Price Over Earnings Overview: Omega Healthcare Invts
Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields
Omega Healthcare Is Maintained at Sector Perform by RBC Capital
Omega Healthcare Invts Analyst Ratings
BofA Securities Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $43
RBC Capital Adjusts Price Target on Omega Healthcare Investors to $43 From $39, Says 'Better Investment Trends Driving Stronger Growth Outlook'; Keeps Sector Perform Rating
Omega Healthcare Investors Inc To Go Ex-Dividend On November 4th, 2024 With 0.67 USD Dividend Per Share
October 31st (Eastern Time) - $Omega Healthcare Investors Inc(OHI.US)$ is trading ex-dividend on November 4th, 2024.Shareholders of record on November 4th, 2024 will receive 0.67 USD dividend per
Omega Healthcare Investors, Inc. (OHI) Q3 2024 Earnings Call Transcript Summary
Omega Healthcare Investors Inc | 10-Q: Q3 2024 Earnings Report
Omega Healthcare Investors Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Adjusted FFO Guidance.
Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
BNP Paribas Upgrades Omega Healthcare Investors Inc(OHI.US) to Buy Rating, Raises Target Price to $49